Blood Pressure News and Research

RSS

Blood Pressure is the force of circulating blood on the walls of the arteries. Blood pressure is taken using two measurements: systolic (measured when the heart beats, when blood pressure is at its highest) and diastolic (measured between heart beats, when blood pressure is at its lowest). Blood pressure is written with the systolic blood pressure first, followed by the diastolic blood pressure (for example 120/80).

Researchers find link between asymptomatic PAD and cardiovascular events among stroke and TIA patients

Measuring circulation in the ankle using a device similar to a blood pressure cuff can help identify asymptomatic peripheral artery disease (PAD) in stroke and transient ischemic attack (TIA) survivors, a group at much higher risk of subsequent cerebrovascular events, according to a study in Stroke: Journal of the American Heart Association.

28 Aug 2009

The Research Partnership study reveals that diabetes can have a major effect on people's lives

A new research study carried out by The Research Partnership reveals that living with diabetes can have a major effect on people's lives, with just under half (44%) of type 2 patients reporting that the condition has impacted on either their ability or their desire to have sex.

28 Aug 2009

Omron Healthcare achieves sale milestone: 100 million blood pressure monitors sold

Omron Healthcare Co., Ltd. announced on August 28 a new sales milestone for blood pressure monitors: 100 million units sold worldwide. The first Omron digital blood pressure monitor was launched in 1973 and since then, Omron Healthcare has introduced more than 100 models used in more than 100 countries around the world.

28 Aug 2009

ADInstruments' latest version of LabTutor helps nursing students

ADInstruments is helping nursing students bridge the gap between the classroom and hospital ward with the latest version of LabTutor and three Nursing Experiment Collections. LabTutor 3.0 supports 19 new experiments (featuring over 100 exercises including patient case studies) that illustrate in practical terms the biological theory taught in nursing anatomy and physiology classrooms.

28 Aug 2009

Leicester research reveals the detrimental effects of Beta blockers on central aortic pressures

A University of Leicester-led study may have uncovered the reason why Beta-blockers are less effective at preventing stroke in older people with high blood pressure, when compared to other drugs for high blood pressure.

28 Aug 2009

Health Canada issues marketing approval for NeuroVasx's cPAX Aneurysm Treatment System

NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that it has received approval to market its cPAX Aneurysm Treatment System in Canada from Health Canada's Therapeutic Products Directorate. In addition to Canadian regulatory approval, the cPAX System also received CE Mark in March 2009.

27 Aug 2009

Cumberland Pharmaceuticals posts $9.8 million revenues for the three months ended June 30, 2009

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on the hospital acute care and gastroenterology markets, today announced second quarter 2009 financial results.

27 Aug 2009

Four medical groups of Resurrection Health Care Preferred earn nine blue stars in the 2009 Blue Star Report

Three out of four medical groups of Resurrection Health Care Preferred (RHCP) have earned nine blue stars, a perfect score, in the 2009 Blue Star Report -- an annual ranking of doctors in medical groups from Blue Cross Blue Shield of Illinois.

27 Aug 2009

Beta-blockers are less effective at preventing stroke in older people with high blood pressure

27 Aug 2009

European Medicines Agency validates Schering-Plough's MAA for nomegestrol acetate/17 beta-estradiol

Schering-Plough Corporation, (NYSE: SGP), today announced that the European Medicines Agency (EMEA) has validated (accepted for review) the company's Marketing Authorization Application (MAA) for a fixed-dose combination of mometasone furoate and formoterol fumarate for the maintenance treatment of asthma in patients 12 years of age and older.

27 Aug 2009

Kudzu vine root extracts may be developed as a dietary supplement for people with metabolic syndrome

Kudzu, the nuisance vine that has overgrown almost 10 million acres in the southeastern United States, may sprout into a dietary supplement.

27 Aug 2009

CardioMEMS raises $22.1M to fund clinical trial of its heart failure pressure measurement system

CardioMEMS, Inc., a medical technology company that has developed and is commercializing proprietary wireless sensing and communication technology for the human body, today announced the completion of a $22.1M financing. The financing provides the company with additional capital to fund the company's CHAMPION clinical trial.

27 Aug 2009

Modest decline for hypertension drug industry over the next decade

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that despite generic erosion of many branded agents -- most notably Novartis's Diovan -- the hypertension drug market will experience only modest decline over the next decade.

26 Aug 2009

Clinical study results of USANA Health Sciences products published in the Obesity and Weight Management journal

USANA Health Sciences, Inc. announced today that results of a large, third-party clinical study involving USANA products, conducted at the University of Colorado Denver (UCD), have been published in the August 2009 edition of the journal Obesity and Weight Management.

26 Aug 2009

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Amgen today announced that in a large, randomized, double-blind, placebo-controlled, Phase 3 study of patients with chronic kidney disease (CKD) (not requiring dialysis), anemia and type-2 diabetes (the Trial to Reduce Cardiovascular Endpoints with Aranesp((R)) Therapy, or TREAT), treatment of anemia with Aranesp((R) )(darbepoetin alfa) to a hemoglobin target of 13 g/dL had no statistically significant effect on either of two primary endpoints compared with placebo treatment.

26 Aug 2009

Task Force guidelines to improve identification and treatment of high BP among young people

Comprehensive guidelines for the treatment and management of hypertension in children and adolescents are being published for the first time in the latest issue of the Journal of Hypertension.

26 Aug 2009

Study reveals high levels of ergothioneine in RBCs of women with pre-eclampsia

A chemical compound found in unpasteurised food has been detected in unusually high levels in the red blood cells of pregnant women with the condition pre-eclampsia.

26 Aug 2009

Socket Mobile collaborates with iBleep and Dakota Integrated Solutions to provide advanced wireless communication systems to healthcare organizations

Socket Mobile, Inc. (NASDAQ: SCKT), an innovative provider of mobile productivity solutions, today announced the formation of a partnership with iBleep Ltd. and Dakota Integrated Solutions in order to provide advanced wireless communication systems to healthcare organizations throughout the National Health Service (NHS) in the United Kingdom and elsewhere.

25 Aug 2009

Impact Fusion International to commence filming of Anti-Steroids and Anti-Drug Campaign

Impact Fusion International, Inc. (PINKSHEETS: IFUS) announced that it will begin filming of its Anti-Steroids and Anti-Drug Campaign with retired NFL star Kenneth Davidson. This campaign will be centered around the Intact Sports Nutrition products Intact Endurance and Intact Protein+ that will be sold as a system called Intact Complete.

25 Aug 2009

Studies reveal that obese men are at increased risk for erectile dysfunction

Obese men are at increased risk for erectile dysfunction (ED), likely caused by atherosclerosis-related hypertension and cardiovascular disease, as well as hormonal changes associated with obesity, as described in a timely article published in Obesity and Weight Management, a journalzine published by Mary Ann Liebert, Inc.

25 Aug 2009

Blood Pressure News and Research

Further Reading

Researchers find link between asymptomatic PAD and cardiovascular events among stroke and TIA patients

The Research Partnership study reveals that diabetes can have a major effect on people's lives

Omron Healthcare achieves sale milestone: 100 million blood pressure monitors sold

ADInstruments' latest version of LabTutor helps nursing students

Leicester research reveals the detrimental effects of Beta blockers on central aortic pressures

Health Canada issues marketing approval for NeuroVasx's cPAX Aneurysm Treatment System

Cumberland Pharmaceuticals posts $9.8 million revenues for the three months ended June 30, 2009

Four medical groups of Resurrection Health Care Preferred earn nine blue stars in the 2009 Blue Star Report

Beta-blockers are less effective at preventing stroke in older people with high blood pressure

European Medicines Agency validates Schering-Plough's MAA for nomegestrol acetate/17 beta-estradiol

Kudzu vine root extracts may be developed as a dietary supplement for people with metabolic syndrome

CardioMEMS raises $22.1M to fund clinical trial of its heart failure pressure measurement system

Modest decline for hypertension drug industry over the next decade

Clinical study results of USANA Health Sciences products published in the Obesity and Weight Management journal

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Task Force guidelines to improve identification and treatment of high BP among young people

Study reveals high levels of ergothioneine in RBCs of women with pre-eclampsia

Socket Mobile collaborates with iBleep and Dakota Integrated Solutions to provide advanced wireless communication systems to healthcare organizations

Impact Fusion International to commence filming of Anti-Steroids and Anti-Drug Campaign

Studies reveal that obese men are at increased risk for erectile dysfunction

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News